toward a CFA, is a plus. About Us: J.P. Morgan is a global leader in financial services, providing strategic advice and products.... Visit our for more information about requesting an accommodation. About the Team: J.P. Morgan's Commercial & Investment...
Job Description: J.P. Morgan Asset Management is a leading investment manager for institutions, financial... of understanding or proficiency in Python or other programming language. About Us: J.P. Morgan is a global leader in financial...
but not required. Cantonese and Mandarin language skills are an advantage. About Us: J.P. Morgan is a global leader in financial services... Team: J.P. Morgan Asset & Wealth Management delivers industry-leading investment management and private banking solutions...
style MBA and/or CFA preferred Proficient in both reading and writing Chinese is required for this role About Us: J.P... an accommodation. About the Team: J.P. Morgan Asset & Wealth Management delivers industry-leading investment management and private...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »